Dyshidrosiform Bullous Pemphigoid Triggered by COVID-19 Vaccination.
| Autor: | Shanshal M; Dermatology, Basildon University Hospital, Basildon, GBR. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2022 Jun 28; Vol. 14 (6), pp. e26383. Date of Electronic Publication: 2022 Jun 28 (Print Publication: 2022). |
| DOI: | 10.7759/cureus.26383 |
| Abstrakt: | Vaccination has made a substantial contribution to global health improvement throughout history. The coronavirus disease 2019 (COVID-19) vaccinations have provided us with a ray of hope for combatting the ongoing pandemic and saving lives. However, following COVID-19 vaccination, a wide spectrum of cutaneous adverse effects have been observed. We report a case of dyshidrosiform bullous pemphigoid, a rare clinical variant of bullous pemphigoid, following COVID-19 vaccination in an elderly female patient. The biopsy revealed subepidermal splitting with positive direct and indirect immunofluorescence studies. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2022, Shanshal et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|